The NIH announced today that it has halted a clinical trial of COVID-19 convalescent plasma among ER patients with mild-to-moderate symptoms after the trial found no significant benefit from the treatment. An independent data and safety monitoring board (DSMB) recommended on Feb. 25 that NIH’s stop enrolling new patients. The Clinical Trial of COVID-19 Convalescent…